Printer Friendly

KGK screening vitamin D levels of Toronto residents.

[ILLUSTRATION OMITTED]

KGK Synergize Inc., a contract research organization, teamed with Toronto Man to Man Prostate Cancer Support Group to sponsor a screening study to evaluate the vitamin D status of volunteers from Toronto, ON. A total of 189 people participated in the screening, which is the largest, to date, one-time cohort of subjects in North America that have been screened for vitamin D levels in their blood.

"Vitamin D deficiency is a worldwide health problem, especially for populations at higher latitudes where sun exposure is at a minimum. Toronto is one such northern location, where, to our knowledge, vitamin D status has not been specifically evaluated," said Mark Moyad, director of preventative and alternative medicine at the University of Michigan Medical Center. "Further, the data linking certain cancers, such as prostate cancer, to vitamin D levels can be strengthened by the addition of more data."

KGK is currently analyzing the results in their laboratory.

KGK Synergize
COPYRIGHT 2009 Chemical Institute of Canada
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:NEWS / NOUVELLES
Publication:Canadian Chemical News
Geographic Code:1CANA
Date:Jan 1, 2009
Words:157
Previous Article:Canadians win Rosell Probiotic Challenge.
Next Article:Dow Corning reducing waste at its facilities.
Topics:


Related Articles
KGK Synergize Inc. (2003 Nutraceuticals World Company Capabilities).
KGK Synergize Inc.
KGK Synergize Inc.
Vitamin D deficiency is common, even in sunny climate.
Nintendo to launch new games console.
Nintendo to launch new games console.
Nintendo to launch new games console.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters